Our experiments showed that Beclin1 was downregulated in the CRS group (Figures 2(e) and 2(f)), which was restored in AGO-treated mice comparable to the levels found in animals subjected to FLX regimens. The gene discussed is BECN1; the disease is congenital rubella syndrome.